Article List

WPRIM Management System> DCMS> International Neurourology Journal> 2016> 20> 1

Volume: 20 Issue: 1

1. Interstitial Cystitis/Bladder Pain Syndrome: A Urologic Mystery.	Page:3—4
2. Learning From Heart Failure: How Will We Lead Bladder Failure Into the Future?.	Page:1—2
3. Rescue of Heart Failure by Mitochondrial Recovery.	Page:5—12
4. Update on the Pathology and Diagnosis of Interstitial Cystitis/Bladder Pain Syndrome: A Review.	Page:13—17
5. 17Beta-Estradiol Inhibits Calcium-Activated Potassium Channel Expressions in Rat Whole Bladder.	Page:18—25
6. Changes in Synaptic Transmission and Long-term Potentiation Induction as a Possible Mechanism for Learning Disability in an Animal Model of Multiple Sclerosis.	Page:26—32
7. Lower Levels of Urinary Nerve Growth Factor Might Predict Recurrent Urinary Tract Infections in Women.	Page:33—39
8. Eight-Year Experience With Botulinum Toxin Type-A Injections for the Treatment of Nonneurogenic Overactive Bladder: Are Repeated Injections Worthwhile?.	Page:40—46
9. Assessment of Proportion of Hidden Patients Having Symptoms of Overactive Bladder and Why Has It Been Hidden in Female Outpatients Admitted to Hospital.	Page:47—52
10. Weakness of the Pelvic Floor Muscle and Bladder Neck Is Predicted by a Slight Rise in Abdominal Pressure During Bladder Filling: A Video Urodynamic Study in Children.	Page:53—58
11. Comparison of Predictive Factors for Postoperative Incontinence of Holmium Laser Enucleation of the Prostate by the Surgeons' Experience During Learning Curve.	Page:59—68
12. Effect of Nerve-Sparing Radical Prostatectomy on Urinary Continence in Patients With Preoperative Erectile Dysfunction.	Page:69—74
13. Clinical Significance of the Resistive Index of Prostatic Blood Flow According to Prostate Size in Benign Prostatic Hyperplasia.	Page:75—80
14. Intravesical OnabotulinumtoxinA Injection for Overactive Orthotopic Ileal Neobladder: Feasibility and Efficacy.	Page:81—85